Related Experiment Video
Updated: Jan 2, 2026
10:11
Author Spotlight: Standardizing Limbal Niche Cell (LNC) Isolation and Characterization to Support Widespread LNC Research
Published on: October 27, 2023
1.4K
Simple limbal epithelial transplantation: Current status and future perspectives
Catherine J Jackson1,2,3, Inger T Myklebust Ernø2, Håkon Ringstad4
1Department of Plastic and Reconstructive Surgery and Institute for Surgical Research, Oslo University Hospital, Oslo, Norway.
Stem Cells Translational Medicine
|December 6, 2019
Summary
Simple limbal epithelial transplantation (SLET) offers a promising treatment for limbal stem cell deficiency (LSCD), restoring corneal epithelium in 83% of cases. This technique provides an effective alternative to traditional methods, improving vision and reducing risks.
Area of Science:
- Ophthalmology
- Regenerative Medicine
- Corneal Surgery
Background:
- Limbal stem cell deficiency (LSCD) causes vision loss and potential blindness due to damage to limbal stem cells.
- Current treatments like conjunctival-limbal autograft (CLAU) and cultured limbal epithelial transplantation (CLET) have limitations.
- LSCD presents with inflammation, neovascularization, and persistent corneal epithelial defects.
Purpose of the Study:
- To review the progress, advantages, and challenges of Simple Limbal Epithelial Transplantation (SLET) since its introduction in 2012.
- To evaluate the efficacy of SLET compared to established LSCD treatments.
- To present findings from 31 studies on SLET outcomes.
Main Methods:
- SLET involves transplanting a small limbal biopsy onto human amniotic membrane placed on the affected cornea.
- The biopsy is divided and distributed, allowing outgrowth to form a new corneal epithelium.
- This technique avoids cell culturing and can be performed in a single operation.
Main Results:
- SLET resulted in corneal epithelium restoration in 83% (336/404) of operations.
- Visual acuity improved in 69% (258/373) of reported cases.
- Success rates are comparable to CLAU and CLET, with reduced risks.
Conclusions:
- SLET is an effective and advantageous technique for treating LSCD.
- It offers benefits such as reduced risk to the donor eye and a streamlined surgical process.
- Further studies are needed to explore SLET's full potential and address existing challenges.
